HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mauro Goldbaum Selected Research

Macular Degeneration (Age-Related Maculopathy)

1/2015Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV).
3/2014Retinal vascular abnormalities in neovascular age-related macular degeneration.
12/2010Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study.
11/2007Pegaptanib sodium for ocular vascular disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mauro Goldbaum Research Topics

Disease

4Macular Degeneration (Age-Related Maculopathy)
01/2015 - 11/2007
4Macular Edema
04/2009 - 10/2005
2Retinal Vein Occlusion
04/2009 - 11/2007
1Retinal Detachment (Retinal Detachments)
01/2022
1Ataxia (Dyssynergia)
09/2021
1Cataract (Cataracts)
02/2021
1Diabetic Retinopathy (Retinopathy, Diabetic)
11/2007
1Choroidal Neovascularization
11/2007
1Vascular Diseases (Vascular Disease)
11/2007
1Diabetes Mellitus
01/2006
1Retinal Neovascularization
01/2006
1Endophthalmitis (Ophthalmia)
10/2005

Drug/Important Bio-Agent (IBA)

5pegaptanib (Macugen)FDA Link
12/2010 - 10/2005
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2009 - 10/2005
2Retinaldehyde (Retinal)IBA
09/2021 - 03/2014
1Ranibizumab (Lucentis)FDA Link
01/2015
1Therapeutic UsesIBA
11/2007
1salicylhydroxamic acid (SHAM)IBA
01/2006
1Fluorescein (Funduscein)FDA LinkGeneric
01/2006

Therapy/Procedure

2Therapeutics
12/2010 - 01/2006
2Injections
01/2006 - 10/2005
1Aftercare (After-Treatment)
01/2022
1Phacoemulsification
02/2021
1Light Coagulation
01/2006